Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Receives Consensus “Hold” Recommendation from Brokerages

0

Fresenius Medical Care AG & Co. KGaA (New York Stock Exchange: FMSGet a rating) received an average rating of “Hold” from the fifteen research companies that cover the title, Marketbeat.com reports. Seven equity research analysts rated the stock with a hold recommendation and three gave the company a buy recommendation. The 1-year average price target among analysts who have reported on the stock in the past year is $45.83.

The FMS has been the subject of several reports by research analysts. Berenberg Bank lowered its price target on Fresenius Medical Care AG & Co. KGaA from €76.70 ($78.27) to €57.95 ($59.13) in a Wednesday, August 10 report. Jefferies Financial Group upgraded Fresenius Medical Care AG & Co. KGaA from an “underperforming” rating to a “buy” rating and raised its price target for the stock from $30.30 to $33.70 in a research note from Monday, June 27. StockNews.com downgraded Fresenius Medical Care AG & Co. KGaA from a “strong buy” rating to a “buy” rating in a Friday, July 15 research note. UBS Group downgraded Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “neutral” rating in a Friday, July 29 research report. Finally, JPMorgan Chase & Co. reduced its price target on Fresenius Medical Care AG & Co. KGaA from €51.00 ($52.04) to €23.00 ($23.47) in a research report from the Monday, August 1.

Hedge funds weigh on Fresenius Medical Care AG & Co. KGaA

Several institutional investors have recently bought and sold shares of the company. Pzena Investment Management LLC increased its stake in Fresenius Medical Care AG & Co. KGaA by 13.8% in the second quarter. Pzena Investment Management LLC now owns 13,176,037 shares of the company worth $328,610,000 after purchasing an additional 1,598,405 shares in the last quarter. First Trust Advisors LP increased its stake in Fresenius Medical Care AG & Co. KGaA by 15.1% in the fourth quarter. First Trust Advisors LP now owns 1,925,326 shares of the company worth $62,496,000 after purchasing an additional 252,768 shares in the last quarter. Cambiar Investors LLC increased its stake in Fresenius Medical Care AG & Co. KGaA by 18.3% in the first quarter. Cambiar Investors LLC now owns 1,363,874 shares of the company worth $45,935,000 after purchasing an additional 210,819 shares in the last quarter. Bank of America Corp DE increased its stake in Fresenius Medical Care AG & Co. KGaA by 27.9% in the first quarter. Bank of America Corp DE now owns 1,083,689 shares of the company worth $36,499,000 after purchasing an additional 236,459 shares in the last quarter. Finally, Millennium Management LLC acquired a new equity stake in Fresenius Medical Care AG & Co. KGaA during the second quarter at a value of $16,738,000. 4.73% of the shares are held by hedge funds and other institutional investors.

Fresenius Medical Care AG & Co. KGaA share performance

FMS inventory opened at $18.39 on Thursday. The stock has a market capitalization of $10.78 billion, a PE ratio of 11.71, a growth price-earnings ratio of 0.92 and a beta of 1.02. Fresenius Medical Care AG & Co. KGaA has a 12-month low of $18.16 and a 12-month high of $40.85. The company has a current ratio of 1.18, a quick ratio of 0.85 and a debt ratio of 0.47. The stock’s 50-day simple moving average is $22.88 and its 200-day simple moving average is $28.87.

About Fresenius Medical Care AG & Co. KGaA

(Get a rating)

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.

See also

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)



Get news and reviews for Fresenius Medical Care AG & Co. KGaA Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com’s free daily email newsletter .

Share.

Comments are closed.